This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Morvan, D. Articles by Madelmont, J. C. Search for Related Content PubMed PubMed Citation Articles by Morvan, D. Articles by Madelmont, J. C.

Melanoma Tumors Acquire a New Phospholipid Metabolism Phenotype under Cystemustine As Revealed by High-Resolution Magic Angle Spinning Proton Nuclear Magnetic Resonance Spectroscopy of Intact Tumor Samples¹

Institut National de la Santé et de la Recherche Médicale U 484 [D. M., A. D., J. P., J. C. M.], and Centre de Lutte Contre le Cancer Jean Perrin, rue Montalembert [D. M., M. D. L.], 63005 Clermont-Ferrand, France

N'-[2-chloroethyl]-N[2-(methylsulfonyl) ethyl]-N'-nitrosourea (cystemustine),a chloroethylnitrosourea antineoplastic drug, provokes cellular proliferation inhibition and redifferentiation, but there was no cell death in B16 melanoma tumors. Because the phospholipid (Plp) metabolism is tightly involved in tumor growth regulation and tumor cell survival, we tested the hypothesis that melanoma tumors undergo adaptive Plp metabolism changes to survive treatment. Measurements of Plp derivatives were performed using a novel proton nuclear magnetic resonance Spectroscopy application using magic angle spinning on intact tumor tissue samples. Phosphatidylcholine levels were obtained from one-dimensional spectra, and relative levels of choline- and ethanolamine-containing compounds were derived from two-dimensional spectra (total correlation spectroscopy sequence). Two major findings emerged from this study: (a) during tumor growth inhibition, there was a transient accumulation of choline, glycerophosphocholine, and glycerophosphoethanolamine and a sustained increase in phosphocholine and phosphoethanolamine, whereas phosphatidylcholine levels remained unchanged; and (b) during tumor growth recovery, only phosphocholine and phosphoethanolamine remained elevated. Therefore, cystemustine-treated B16 melanoma tumors acquire a new Plp metabolism phenotype, a mechanism that could participate in tumor cell redifferentiation and/or survival.

This article has been cited by other articles:

				D. Morvan and A. Demidem Metabolomics by Proton Nuclear Magnetic Resonance Spectroscopy of the Response to Chloroethylnitrosourea Reveals Drug Efficacy and Tumor Adaptive Metabolic Pathways Cancer Res., March 1, 2007; 67(5): 2150 - 2159. [Abstract] [Full Text] [PDF]

				L. G. Astrakas, I. Goljer, S. Yasuhara, K. E. Padfield, Q. Zhang, S. Gopalan, M. N. Mindrinos, G. Dai, Y.-M. Yu, J. A. J. Martyn, et al. Proton NMR spectroscopy shows lipids accumulate in skeletal muscle in response to burn trauma-induced apoptosis FASEB J, September 1, 2005; 19(11): 1431 - 1440. [Abstract] [Full Text] [PDF]

				F. Djouad, P. Plence, C. Bony, P. Tropel, F. Apparailly, J. Sany, D. Noel, and C. Jorgensen Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals Blood, November 15, 2003; 102(10): 3837 - 3844. [Abstract] [Full Text] [PDF]